AMYRIS HOSTS SUCCESSFUL INVESTOR EVENT
Amyris, a synthetic biotechnology leader, hosted a successful investor event on April 11, 2022, following its Nasdaq Opening Bell ceremony. Key highlights included presentations on its sustainable consumer brands powered by its Lab-to-Market™ technology platform and an update on its precision fermentation plant in Barra Bonita, Brazil, which recently began commissioning operations. The event also featured a consumer panel discussing trends in clean beauty and the benefits of Amyris' proprietary technology. CEO John Melo emphasized the company’s commitment to sustainable products and their increasing consumer appeal.
- Successful investor event showcases company progress and technology.
- Precision fermentation plant in Brazil begins commissioning, indicating expansion.
- Strong consumer interest in Amyris' sustainable beauty brands.
- None.
EMERYVILLE, Calif., April 14, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform, successfully hosted an in-person investor event following the Company's Nasdaq Opening Bell Ringing Ceremony. The investor event, which took place on Monday, April 11, 2022, included a presentation, a video update on the Company's precision fermentation plant in Barra Bonita, Brazil, and a moderated Consumer-oriented panel discussion.
The event, attended by members of the investor community, analysts and editors, was opened by Han Kieftenbeld, Chief Financial Officer, highlighting how far Amyris has progressed its unique capabilities and portfolio since it first rang the bell on September 28, 2010. The program featured a company overview by John Melo, President and Chief Executive Officer, detailing how Amyris' sustainable consumer brands, including Biossance®, Pipette®, JVN Hair ™, and Rose Inc.™, are powered by the Company's proprietary Lab-to-Market™ technology platform and clean ingredients. Also discussed was the greenfield site at Barra Bonita being a strategic investment with which Amyris leads the biotechnology sector with manufacturing at industrial scale, and much needed fermentation capacity.
These presentation materials are available on the Investor Relations section of the company's website at https://investors.amyris.com/events-and-presentations.
The presentation was followed by a video update of the progress made to date on the Company's precision fermentation plant under construction in Barra Bonita, Brazil. The video of the plant, which recently began commissioning operations, is available on Amyris' YouTube channel.
The event concluded with a consumer panel discussion on Amyris' brands moderated by Oliver Chen, Managing Director and senior equity research analyst at Cowen & Company covering retail and luxury goods. Panelists included Caroline Hadfield, CEO Rose Inc.; Catherine Gore, President Biossance and JVN; Mike Rytokoski, President Technology Access; and Annie Tsong, Chief Strategy Officer Products and Ingredients. This discussion detailed clean beauty industry trends, benefits to consumers derived from the Company's vertical integration of proprietary technology, precision manufacturing through fermentation, and high-performance sustainable consumer products.
"We were very pleased to be in-person with various stakeholders to highlight our award-winning consumer brands leading the clean beauty movement, and the work we are doing at Amyris to deliver on the promise of synthetic biology," commented Mr. Melo. "It was an exciting day for all our people at Amyris to see us ring the bell and bring attention to the positive impact our technology and products have on the health of people and planet. We are executing very well creating, manufacturing, and selling some of the world's leading sustainable ingredients and consumer products which are at the core of our winning business model. Our brands are loved by consumers and offer high quality, science-backed solutions that present consumers with sustainable high performing products."
About Amyris
Amyris (Nasdaq: AMRS) is a leading synthetic biotechnology company, transitioning the Clean Health & Beauty and Flavors & Fragrances markets to sustainable ingredients through fermentation and the company's proprietary Lab-to-Market™ technology platform. This Amyris platform leverages state-of-the-art machine learning, robotics and artificial intelligence, enabling the company to rapidly bring new innovation to market at commercial scale. Amyris ingredients are included in over 20,000 products from the world's top brands, reaching more than 300 million consumers. Amyris also owns and operates a family of consumer brands that is constantly evolving to meet the growing demand for sustainable, effective and accessible products. For more information, please visit http://www.amyris.com.
Amyris, the Amyris logo and Lab-to-Market are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries.
View original content to download multimedia:https://www.prnewswire.com/news-releases/amyris-hosts-successful-investor-event-301525602.html
SOURCE Amyris, Inc.
